Publications – 2018

  • Matos JD, Waks JW, Zimetbaum PJ. Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation. J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3116-3125. doi: 10.19102/icrm.2018.090404. eCollection 2018 Apr.
  • Gibson CM, Jennings LK, Chi G, Yee MK, Halaby R, Nafee T, AlKhalfan F, Kerneis M, Korjian S, Daaboul Y, Goldhaber SZ, Hull RD, Hernandez AF, Cohen AT, Harrington RA. Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial. TH Open. 2018 Jan 8;2(1):e16-e24. doi: 10.1055/s-0037-1615288. eCollection 2018 Jan.
  • Ebrille E, Contreras-Valdes FM, Zimetbaum PJ. Hemodynamic response to supraventricular tachycardia in a patient with hypertrophic cardiomyopathy. HeartRhythm Case Rep. 2018 Dec 23;5(4):191-195. doi: 10.1016/j.hrcr.2018.12.006. eCollection 2019 Apr.
  • Ge W, Huh JW, Park YR, Lee JH, Kim YH, Turchin A. An Interpretable ICU Mortality Prediction Model Based on Logistic Regression and Recurrent Neural Networks with LSTM units. AMIA Annu Symp Proc. 2018 Dec 5;2018:460-469. eCollection 2018.
  • Ganatra S, Sharma A, D’Agostino R, Gage T, Kinnunen P. Mycobacterium Chimaera Mimicking Sarcoidosis. Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):301-302. doi: 10.14797/mdcj-14-4-301.
  • Secemsky EA, Carroll BJ, Yeh RW. Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device?. JAMA Netw Open. 2018 Jul 6;1(3):e180453. doi: 10.1001/jamanetworkopen.2018.0453.
  • Mosepele M, Regan S, Massaro J, Meigs JB, Zanni MV, D’Agostino RB Sr, Grinspoon SK, Triant VA. Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals. Open Forum Infect Dis. 2018 Dec 13;5(12):ofy326. doi: 10.1093/ofid/ofy326. eCollection 2018 Dec.
  • Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018 Dec 25;320(24):2542-2552. doi: 10.1001/jama.2018.19232.
  • Petruzzelli MF, Vasti MP, Errico A, D’Agostino R, Tramacere F, Gianicolo EAL, Bambace S, Andreassi MG, Picano E, Portaluri M. Ultrasound B-lines for detection of late lung fibrosis in breast cancer patients after radiation therapy. Ann Ist Super Sanita. 2018 Oct-Dec;54(4):294-299. doi: 10.4415/ANN_18_04_05.
  • Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
  • Reynolds MR, Hlatky MA. Replace or Repair?. Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e005093. doi: 10.1161/CIRCOUTCOMES.118.005093.
  • Jones MR, Howard G, Roubin GS, Blackshear JL, Cohen DJ, Cutlip DE, Leimgruber PP, Rhodes D, Prineas RJ, Glasser SP, Lal BK, Voeks JH, Brott TG; CREST Investigators. Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST. Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004663. doi: 10.1161/CIRCOUTCOMES.117.004663.
  • Blumenthal DM, Strom JB, Valsdottir LR, Howard SE, Wagle NW, Ho KKL, Horn DM, O’Keefe SM, Wasfy JH, Metlay JP, Yeh RW. Patient-Reported Outcomes in Cardiology. Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004794. doi: 10.1161/CIRCOUTCOMES.118.004794.
  • Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A. Pulmonary Production of Soluble ST2 in Heart Failure. Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488.
  • Yeh RW, Valsdottir LR, Yeh MW, Shen C, Kramer DB, Strom JB, Secemsky EA, Healy JL, Domeier RM, Kazi DS, Nallamothu BK; PARACHUTE Investigators. Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial. BMJ. 2018 Dec 13;363:k5094. doi: 10.1136/bmj.k5094.
  • Kundi H, Popma JJ, Valsdottir LR, Shen C, Faridi KF, Pinto DS, Yeh RW. The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. Can J Cardiol. 2018 Dec;34(12):1648-1654. doi: 10.1016/j.cjca.2018.10.002. Epub 2018 Oct 13.
  • Shavadia JS, Vo MN, Bainey KR. Challenges With Severe Coronary Artery Calcification in Percutaneous Coronary Intervention: A Narrative Review of Therapeutic Options. Can J Cardiol. 2018 Dec;34(12):1564-1572. doi: 10.1016/j.cjca.2018.07.482. Epub 2018 Aug 14.
  • Inohara T, Manandhar P, Kosinski AS, Matsouaka RA, Kohsaka S, Mentz RJ, Thourani VH, Carroll JD, Kirtane AJ, Bavaria JE, Cohen DJ, Kiefer TL, Gaca JG, Kapadia SR, Peterson ED, Vemulapalli S. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement. JAMA. 2018 Dec 4;320(21):2231-2241. doi: 10.1001/jama.2018.18077.
  • Das SR, Everett BM, Birtcher KK, Brown JM, Cefalu WT, Januzzi JL Jr, Kalyani RR, Kosiborod M, Magwire ML, Morris PB, Sperling LS. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26.
  • DeFilippis EM, Lau ES, Wei J, Hayes SN, Wood MJ. Where are the women in academic cardiology?. Lancet. 2018 Nov 17;392(10160):2152-2153. doi: 10.1016/S0140-6736(18)32618-7.
  • Elmariah S, McCarthy C, Ibrahim N, Furman D, Mukai R, Magaret C, Rhyne R, Barnes G, van Kimmenade RRJ, Januzzi JL Jr. Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study. Open Heart. 2018 Nov 1;5(2):e000916. doi: 10.1136/openhrt-2018-000916. eCollection 2018.
  • Arnold SV, Li Z, Vemulapalli S, Baron SJ, Mack MJ, Kosinski AS, Reynolds MR, Hermiller JB, Rumsfeld JS, Cohen DJ. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry. JAMA Cardiol. 2018 Dec 1;3(12):1151-1159. doi: 10.1001/jamacardio.2018.3359.
  • Khariton Y, Airhart S, Salisbury AC, Spertus JA, Gosch KL, Grantham JA, Karmpaliotis D, Moses JW, Nicholson WJ, Cohen DJ, Lombardi W, Sapontis J, McCabe JM. Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry. JACC Cardiovasc Interv. 2018 Nov 26;11(22):2276-2283. doi: 10.1016/j.jcin.2018.07.058.
  • Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL Jr, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, O’Connor CM, Felker GM. Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. J Am Coll Cardiol. 2018 Nov 27;72(21):2551-2562. doi: 10.1016/j.jacc.2018.08.2184.
  • Kapadia SR, Huded CP, Kodali SK, Svensson LG, Tuzcu EM, Baron SJ, Cohen DJ, Miller DC, Thourani VH, Herrmann HC, Mack MJ, Szerlip M, Makkar RR, Webb JG, Smith CR, Rajeswaran J, Blackstone EH, Leon MB; PARTNER Trial Investigators. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial. J Am Coll Cardiol. 2018 Nov 13;72(20):2415-2426. doi: 10.1016/j.jacc.2018.08.2172.
  • Lindholm D, James SK, Gabrysch K, Storey RF, Himmelmann A, Cannon CP, Mahaffey KW, Steg PG, Held C, Siegbahn A, Wallentin L. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. JAMA Cardiol. 2018 Dec 1;3(12):1160-1166. doi: 10.1001/jamacardio.2018.3811.
  • Gaggin HK, Januzzi JL Jr. Moving the Needle Toward a More Personalized Means of Patient Care. JAMA Cardiol. 2018 Dec 1;3(12):1146-1148. doi: 10.1001/jamacardio.2018.3900.
  • Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, Hull RD, Hernandez AF, Cohen AT, Harrington RA, Goldhaber SZ. Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial. Thromb Haemost. 2018 Dec;118(12):2046-2052. doi: 10.1055/s-0038-1675606. Epub 2018 Nov 12.
  • Spitzer E, Cannon CP, Serruys PW. Should real-world evidence be incorporated into regulatory approvals?. Expert Opin Drug Saf. 2018 Dec;17(12):1155-1159. doi: 10.1080/14740338.2018.1546842. Epub 2018 Nov 14.
  • Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL Jr, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 Dec 25;72(25):3370-3372. doi: 10.1016/j.jacc.2018.08.2202.
  • Januzzi JL Jr, Elmariah S. A Stitch in Time: Biomarker-Guided Timing of Aortic Valve Replacement for Severe Aortic Stenosis?. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2182-2184. doi: 10.1016/j.jcin.2018.08.018.
  • Ravikanth R, Pinto DS, Mathew S. Olfactory groove meningioma masquerading as psychiatric disturbances. Indian J Psychiatry. 2018 Jul-Sep;60(3):367-369. doi: 10.4103/psychiatry.IndianJPsychiatry_267_17.
  • Saad F, Doros G, Haider KS, Haider A. Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms. Investig Clin Urol. 2018 Nov;59(6):399-409. doi: 10.4111/icu.2018.59.6.399. Epub 2018 Nov 2.
  • Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL Jr. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. J Am Coll Cardiol. 2018 Nov 6;72(19):2309-2320. doi: 10.1016/j.jacc.2018.08.2165.
  • Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH, Yeh RW, Secemsky EA. Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy. PLoS One. 2018 Oct 31;13(10):e0205457. doi: 10.1371/journal.pone.0205457. eCollection 2018.
  • Capodanno D, Mehran R, Gibson CM, Angiolillo DJ. CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction. Expert Opin Investig Drugs. 2018 Dec;27(12):997-1005. doi: 10.1080/13543784.2018.1543399. Epub 2018 Nov 3.
  • Correa S, Morrow DA, Braunwald E, Davies RY, Goodrich EL, Murphy SA, Cannon CP, O’Donoghue ML. Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome. J Am Heart Assoc. 2018 Oct 16;7(20):e009077. doi: 10.1161/JAHA.118.009077.
  • White WB, Jalil F, Cushman WC, Bakris GL, Bergenstal R, Heller SR, Liu Y, Mehta C, Zannad F, Cannon CP. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial. J Am Heart Assoc. 2018 Oct 16;7(20):e009114. doi: 10.1161/JAHA.118.009114.
  • Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Eckel RH, Cannon CP, Lee LV, Bessac L, Pordy R, Letierce A, Ray KK. Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. J Am Heart Assoc. 2018 Sep 18;7(18):e009221. doi: 10.1161/JAHA.118.009221.
  • Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D’Agostino RB Sr, Massaro JM, van der Graaf Y, Cramer MJM, Kappelle LJ, de Borst GJ, Steg PG, Visseren FLJ. Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model. J Am Heart Assoc. 2018 Aug 21;7(16):e009217. doi: 10.1161/JAHA.118.009217.
  • Martin LM, Januzzi JL Jr, Thompson RW, Ferris TG, Singh JP, Bhambhani V, Wasfy JH. Clinical Profile of Acute Myocardial Infarction Patients Included in the Hospital Readmissions Reduction Program. J Am Heart Assoc. 2018 Aug 21;7(16):e009339. doi: 10.1161/JAHA.118.009339.
  • Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O’Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018 Oct 30;72(18):2109-2119. doi: 10.1016/j.jacc.2018.07.093.
  • Ibrahim NE, Januzzi JL Jr. Established and Emerging Roles of Biomarkers in Heart Failure. Circ Res. 2018 Aug 17;123(5):614-629. doi: 10.1161/CIRCRESAHA.118.312706.
  • Berry NC, Kereiakes DJ, Yeh RW, Steg PG, Cutlip DE, Jacobs AK, Abbott JD, Hsieh WH, Massaro JM, Mauri L; DAPT Study Investigators. Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women. Circ Cardiovasc Interv. 2018 Aug;11(8):e005308. doi: 10.1161/CIRCINTERVENTIONS.117.005308.
  • Roguin A, Kandzari DE, Marcusohn E, Koolen JJ, Doros G, Massaro JM, Garcia-Garcia HM, Bennett J, Gharib EG, Cutlip DE, Waksman R. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. Circ Cardiovasc Interv. 2018 Oct;11(10):e007331. doi: 10.1161/CIRCINTERVENTIONS.118.007331.
  • Wadhera RK, Yeh RW. Inadequate Surrogates for Imperfect Quality Measures. Circ Cardiovasc Interv. 2018 Sep;11(9):e007216. doi: 10.1161/CIRCINTERVENTIONS.118.007216.
  • Arnold SV, Cohen DJ, Dai D, Jones PG, Li F, Thomas L, Baron SJ, Frankel NZ, Strong S, Matsouaka RA, Edwards FH, Brennan JM. Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population. Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e004693. doi: 10.1161/CIRCOUTCOMES.118.004693.
  • Kundi H, Valsdottir LR, Popma JJ, Cohen DJ, Strom JB, Pinto DS, Shen C, Yeh RW. Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e005048. doi: 10.1161/CIRCOUTCOMES.118.005048.
  • Januzzi JL Jr, Packer M, Claggett B, Liu J, Shah AM, Zile MR, Pieske B, Voors A, Gandhi PU, Prescott MF, Shi V, Lefkowitz MP, McMurray JJV, Solomon SD. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure. Circ Heart Fail. 2018 Oct;11(10):e005133. doi: 10.1161/CIRCHEARTFAILURE.118.005133.
  • Lundberg GP, Mehta LS, Sanghani RM, Patel HN, Aggarwal NR, Aggarwal NT, Braun LT, Lewis SJ, Mieres JH, Wood MJ, Harrington RA, Volgman AS. Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular Disease. Circulation. 2018 Sep 11;138(11):1155-1165. doi: 10.1161/CIRCULATIONAHA.118.035351.
  • Anter E, Duytschaever M, Shen C, Strisciuglio T, Leshem E, Contreras-Valdes FM, Waks JW, Zimetbaum PJ, Kumar K, Spector PS, Lee A, Gerstenfeld EP, Nakar E, Bar-Tal M, Buxton AE. Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006536. doi: 10.1161/CIRCEP.118.006536.
  • Maslov MY, Foianini S, Orlov MV, Januzzi JL, Lovich MA. A Novel Paradigm for Sacubitril/Valsartan: Beta-Endorphin Elevation as a Contributor to Exercise Tolerance Improvement in Rats With Preexisting Heart Failure Induced by Pressure Overload. J Card Fail. 2018 Nov;24(11):773-782. doi: 10.1016/j.cardfail.2018.10.006. Epub 2018 Oct 19.
  • Kundi H, Strom JB, Valsdottir LR, Elmariah S, Popma JJ, Shen C, Yeh RW. Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2148-2156. doi: 10.1016/j.jcin.2018.07.002. Epub 2018 Oct 17.
  • Drudi LM, Ades M, Asgar A, Perrault L, Lauck S, Webb JG, Rassi A, Lamy A, Noiseux N, Peterson MD, Labinaz M, Lefèvre T, Popma JJ, Kim DH, Martucci G, Piazza N, Afilalo J. Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2185-2192. doi: 10.1016/j.jcin.2018.06.037. Epub 2018 Oct 17.
  • Feldman T, Smith R 2nd, Popma JJ. Primary MR remains undertreated. Cardiovasc Revasc Med. 2018 Dec;19(8):905-906. doi: 10.1016/j.carrev.2018.10.015. Epub 2018 Oct 15.
  • Korjian S, Braunwald E, Daaboul Y, Mi M, Bhatt DL, Verheugt FWA, Cohen M, Bode C, Burton P, Plotnikov AN, Gibson CM. Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). Am J Cardiol. 2018 Dec 1;122(11):1896-1901. doi: 10.1016/j.amjcard.2018.08.034. Epub 2018 Sep 7.
  • Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O’Gara PT, Fox KAA. [Fourth universal definition of myocardial infarction (2018)]. Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203.
  • Ko SQ, Valsdottir LR, Strom JB, Cheng YC, Hirayama A, Liu PH, Yanagisawa N, Yen H, Shen C, Yeh RW. Meta-Analysis of Bleeding Risk Prediction Scores in Patients After Percutaneous Coronary Intervention on Dual Antiplatelet Therapy. Am J Cardiol. 2018 Dec 1;122(11):1843-1852. doi: 10.1016/j.amjcard.2018.08.025. Epub 2018 Sep 8.
  • Kandzari DE, Grantham JA, Karmpaliotis D, Lombardi W, Moses JW, Nicholson W, Cook S, Pershad A, Popma JJ. Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study. Coron Artery Dis. 2018 Dec;29(8):618-623. doi: 10.1097/MCA.0000000000000668.
  • Shah AB, Zilinski J, Brown MG, Neary JH, Weiner RB, Hutter AM, Apple FS, Picard MH, Januzzi JL, Baggish AL. Endurance Exercise Training Attenuates Natriuretic Peptide Release During Maximal Effort Exercise: Biochemical Correlates of the “Athlete’s Heart”. J Appl Physiol (1985). 2018 Oct 11. doi: 10.1152/japplphysiol.00293.2018. Online ahead of print.
  • Ballantyne CM, Bhatt DL, Cannon CP, Fazio S, Sabatine MS. WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management. Am J Cardiol. 2018 Aug 16:S0002-9149(18)31653-9. doi: 10.1016/j.amjcard.2018.08.020. Online ahead of print.
  • Nafee T, Gibson CM, Yee MK, Alkhalfan F, Chi G, Travis R, Mir M, Kalayci A, Jafarizade M, Ganti A, Kazmi SH, Ghaffarpasand E, Pitliya A, Datta S, Sharfaei S, Alihashemi M, Elsaiey A, Qamar I, Jahansouz M, Talib U, Kahe F, Habibi S, Abdelwahed M, Tariq F, Kaur M, Younes A, Walia SS, Singh A, Dildar SM, Afzal MK, Kerneis M. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. Expert Rev Cardiovasc Ther. 2018 Nov;16(11):845-855. doi: 10.1080/14779072.2018.1534068. Epub 2018 Oct 15.
  • Hernandez AF, Green JB, Janmohamed S, D’Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.
  • Reimold FR, Reynolds MR. Proarrhythmia and death with antiarrhythmic drugs for atrial fibrillation, and the unfulfilled promise of comparative effectiveness research. Am Heart J. 2018 Nov;205:128-130. doi: 10.1016/j.ahj.2018.08.011. Epub 2018 Sep 12.
  • Cannon CP, McGuire DK, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Charbonnel B, Shih WJ, Gallo S, Masiukiewicz U, Golm G, Cosentino F, Lauring B, Terra SG; VERTIS-CV Investigators. Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). Am Heart J. 2018 Dec;206:11-23. doi: 10.1016/j.ahj.2018.08.016. Epub 2018 Sep 5.
  • Gibson CM, Nafee T, Kerneis M. Conundrum of Using Real-World Observational Data to Inform Real-World Conclusions About Safety and Efficacy. J Am Coll Cardiol. 2018 Oct 9;72(15):1801-1803. doi: 10.1016/j.jacc.2018.07.053.
  • Stone GW, Baron SJ, Cohen DJ. Quality-of-Life Assessment in the EXCEL Trial. JACC Cardiovasc Interv. 2018 Oct 8;11(19):2014. doi: 10.1016/j.jcin.2018.07.028.
  • Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23.
  • Sorrentino S, Giustino G, Baber U, Sartori S, Cohen DJ, Henry TD, Farhan S, Sharma M, Ariti C, Dangas G, Gibson M, Faggioni M, Krucoff MW, Aquino M, Chandrasekhar J, Moliterno DJ, Colombo A, Vogel B, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R. Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). Am J Cardiol. 2018 Nov 15;122(10):1638-1646. doi: 10.1016/j.amjcard.2018.07.041. Epub 2018 Aug 20.
  • Tajti P, Burke MN, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Datilo P, Toma C, Smith AJC, Uretsky B, Holper E, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Jaber W, Samady H, Rangan BV, Xenogiannis I, Ungi I, Banerjee S, Brilakis ES. Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry. Can J Cardiol. 2018 Oct;34(10):1264-1274. doi: 10.1016/j.cjca.2018.07.472. Epub 2018 Jul 31.
  • Kandzari DE, Koolen JJ, Doros G, Massaro JJ, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R; BIOFLOW V Investigators. Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents. J Am Coll Cardiol. 2018 Dec 25;72(25):3287-3297. doi: 10.1016/j.jacc.2018.09.019. Epub 2018 Sep 23.
  • Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH; CoreValve U.S. Pivotal High Risk Trial Clinical Investigators. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 Dec 4;72(22):2687-2696. doi: 10.1016/j.jacc.2018.08.2146. Epub 2018 Sep 21.
  • Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O’Donoghue ML, Antman EM, Newby LK, Sabatine MS, Giugliano RP. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 Nov 7;39(42):3810-3820. doi: 10.1093/eurheartj/ehy556.
  • Gug C, Huțanu D, Vaida M, Doroş G, Popa C, Stroescu R, Furău G, Furău C, Grigoriță L, Mozos I. De novo unbalanced translocation t(15;22)(q26.2;q12) with velo-cardio-facial syndrome: A case report and review of the literature. Exp Ther Med. 2018 Oct;16(4):3589-3595. doi: 10.3892/etm.2018.6609. Epub 2018 Aug 16.
  • Vergaro G, Januzzi JL Jr, Cohen Solal A, Aimo A, Arzilli C, Zyw L, Valleggi A, Giannoni A, Prontera C, Barison A, Poletti R, Gabutti A, Mammini C, Passino C, Emdin M. NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure. Int J Cardiol. 2018 Nov 15;271:324-330. doi: 10.1016/j.ijcard.2018.04.006.
  • Mauri L, Kirtane AJ, Windecker S, Yeh RW, Dauerman HL, Price MJ, Christen T, Allocco DJ, Meredith IT, Kereiakes DJ. Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention. Am Heart J. 2018 Nov;205:110-117. doi: 10.1016/j.ahj.2018.08.004. Epub 2018 Aug 17.
  • Tajti P, Karatasakis A, Danek BA, Alaswad K, Karmpaliotis D, Jaffer FA, Choi JW, Yeh RW, Patel M, Mahmud E, Burke MN, Krestyaninov O, Khelimskii D, Toma C, Doing AH, Uretsky B, Koutouzis M, Tsiafoutis I, Wyman RM, Garcia S, Holper E, Xenogiannis I, Rangan BV, Banerjee S, Ungi I, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. J Invasive Cardiol. 2018 Nov;30(11):E113-E121. Epub 2018 Sep 15.
  • AlKhalfan F, Kerneis M, Nafee T, Yee MK, Chi G, Plotnikov A, Braunwald E, Gibson CM. D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). Am J Cardiol. 2018 Nov 1;122(9):1459-1464. doi: 10.1016/j.amjcard.2018.07.032. Epub 2018 Aug 4.
  • Ibrahim NE, Gupta R, Lyass A, Li Y, Shrestha S, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Massaro JM, D’Agostino RB Sr, Januzzi JL Jr. Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Chem. 2018 Nov;64(11):1617-1625. doi: 10.1373/clinchem.2017.286385. Epub 2018 Sep 13.
  • Pérez-Martínez MT, Lacunza-Ruiz J, García de Lara J, Noguera-Velasco JA, Lax A, Hernández-Vicente Á, Asensio-López MC, Januzzi JL Jr, Ibañez B, Pascual-Figal DA. Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2018 Sep 18;72(12):1429-1430. doi: 10.1016/j.jacc.2018.06.062.
  • Davis S, Rungruangphol PD, Gibson CM. Maximizing Benefits With the Medication Use Evaluation Process. Hosp Pharm. 2018 Oct;53(5):284-285. doi: 10.1177/0018578718775330. Epub 2018 May 8.
  • Stone GW, Généreux P, Harrington RA, White HD, Gibson CM, Steg PG, Hamm CW, Mahaffey KW, Price MJ, Prats J, Deliargyris EN, Bhatt DL. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial. Eur Heart J. 2018 Dec 7;39(46):4112-4121. doi: 10.1093/eurheartj/ehy562.
  • Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Toma C, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure. Am J Cardiol. 2018 Aug 1;122(3):381-387. doi: 10.1016/j.amjcard.2018.04.021. Epub 2018 May 1.
  • Ambrosy AP, Cerbin LP, Fudim M, Clare RM, Lokhnygina Y, Braunwald E, Califf RM, Cannon CP, Tershakovec AM, Roe MT, Blazing MA. Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status. Am J Cardiol. 2018 Nov 1;122(9):1451-1458. doi: 10.1016/j.amjcard.2018.07.034. Epub 2018 Aug 4.
  • Grayburn PA, Oh JK, Reardon MJ, Popma JJ, Deeb GM, Boulware M, Huang J, Stoler RC. Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial). Am J Cardiol. 2018 Nov 1;122(9):1527-1535. doi: 10.1016/j.amjcard.2018.07.018. Epub 2018 Aug 3.
  • Ebrille E, Chang JD, Zimetbaum PJ. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads. Card Electrophysiol Clin. 2018 Sep;10(3):447-452. doi: 10.1016/j.ccep.2018.05.006. Epub 2018 Jul 20.
  • Sidhu RS, Tyrrell BD, Welsh RC, Meyer SR, Shanks M, Bainey KR. Transcatheter Mitral Valve Intervention for Chronic Mitral Regurgitation: A Plethora of Different Technologies. Can J Cardiol. 2018 Sep;34(9):1200-1209. doi: 10.1016/j.cjca.2018.04.034. Epub 2018 Jul 12.
  • Pencina KM, D’Agostino RB, Vasan RS, Pencina MJ. Microsimulation model to predict incremental value of biomarkers added to prognostic models. J Am Med Inform Assoc. 2018 Oct 1;25(10):1382-1385. doi: 10.1093/jamia/ocy108.
  • Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.
  • McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, Wasfy JH, Januzzi JL Jr. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 Sep 4;72(10):1166-1170. doi: 10.1016/j.jacc.2018.06.055.
  • Writing Committee Members, Hirshfeld JW Jr, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L; ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL Jr, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E35-E97. doi: 10.1002/ccd.27659. Epub 2018 Aug 29.
  • Writing Committee Members, Hirshfeld JW Jr, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L; ACC Task Force on Expert Consensus Decision Pathways, Januzzi JL Jr, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):203-221. doi: 10.1002/ccd.27660. Epub 2018 Aug 29.
  • Writing Committee Members, Hirshfeld JW Jr, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L; ACC Task Force On Expert Consensus Decision Pathways, Januzzi JL Jr, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):222-246. doi: 10.1002/ccd.27661. Epub 2018 Aug 29.
  • Sharma S, Wood MJ. The Global Burden of Cardiovascular Disease in Women. Curr Treat Options Cardiovasc Med. 2018 Aug 27;20(10):81. doi: 10.1007/s11936-018-0676-1.
  • Siracuse JJ, Paracha M, Farber A, Rybin D, Doros G, Tseng J, McAneny D, Sachs T. Never events after hepatopancreatobiliary operations. Am J Surg. 2018 Dec;216(6):1129-1134. doi: 10.1016/j.amjsurg.2018.06.029. Epub 2018 Jun 30.
  • Chhatriwalla AK, Saxon JT, Cohen DJ, Allen KB. Is Bioprosthetic Valve Fracture Beneficial for Patients with Larger Surgical Valves Undergoing Valve in Valve TAVR?. Curr Cardiol Rep. 2018 Aug 22;20(10):95. doi: 10.1007/s11886-018-1035-2.
  • Bainey KR, Alemayehu W, Gupta AK, Bowker SL, Welsh RC, Kaul P. Ethnic and sex differences in ambulance activation among hospitalized patients with acute coronary syndromes: Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol. 2018 Dec 1;272:33-39. doi: 10.1016/j.ijcard.2018.08.035. Epub 2018 Aug 10.
  • Ciliberti MP, D’Agostino R, Gabrieli L, Nikolaou A, Sardaro A. The radiation therapy options of intracranial hemangiopericytoma: An overview and update on a rare vascular mesenchymal tumor. Oncol Rev. 2018 Jul 10;12(2):354. doi: 10.4081/oncol.2018.354. eCollection 2018 Jul 4.
  • Kerneis M, Gibson CM, Cohen M. Reply: In Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention, One Size Cannot Fit All. JACC Cardiovasc Interv. 2018 Aug 13;11(15):1539-1540. doi: 10.1016/j.jcin.2018.04.028.
  • Rice ME, Galang RR, Roth NM, Ellington SR, Moore CA, Valencia-Prado M, Ellis EM, Tufa AJ, Taulung LA, Alfred JM, Pérez-Padilla J, Delgado-López CA, Zaki SR, Reagan-Steiner S, Bhatnagar J, Nahabedian JF 3rd, Reynolds MR, Yeargin-Allsopp M, Viens LJ, Olson SM, Jones AM, Baez-Santiago MA, Oppong-Twene P, VanMaldeghem K, Simon EL, Moore JT, Polen KD, Hillman B, Ropeti R, Nieves-Ferrer L, Marcano-Huertas M, Masao CA, Anzures EJ, Hansen RL Jr, Pérez-Gonzalez SI, Espinet-Crespo CP, Luciano-Román M, Shapiro-Mendoza CK, Gilboa SM, Honein MA. Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection – U.S. Territories and Freely Associated States, 2018. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867. doi: 10.15585/mmwr.mm6731e1.
  • Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Popma JJ, Gao R, Stone GW. Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial. EuroIntervention. 2018 Aug 3;14(5):e554-e561. doi: 10.4244/EIJ-D-17-00796.
  • Gibson CM, Chasmer LE, Thompson DK, Quinton WL, Flannigan MD, Olefeldt D. Wildfire as a major driver of recent permafrost thaw in boreal peatlands. Nat Commun. 2018 Aug 2;9(1):3041. doi: 10.1038/s41467-018-05457-1.
  • Parikh KS, Sharma K, Fiuzat M, Surks HK, George JT, Honarpour N, Depre C, Desvigne-Nickens P, Nkulikiyinka R, Lewis GD, Gomberg-Maitland M, O’Connor CM, Stockbridge N, Califf RM, Konstam MA, Januzzi JL Jr, Solomon SD, Borlaug BA, Shah SJ, Redfield MM, Felker GM. Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials. JACC Heart Fail. 2018 Aug;6(8):619-632. doi: 10.1016/j.jchf.2018.06.008.
  • Aimo A, Januzzi JL Jr, Vergaro G, Petersen C, Pasanisi EM, Molinaro S, Passino C, Emdin M. Left ventricular ejection fraction for risk stratification in chronic systolic heart failure. Int J Cardiol. 2018 Dec 15;273:136-140. doi: 10.1016/j.ijcard.2018.07.117. Epub 2018 Jul 24.
  • Potluri R, Carter PR, Lavu D, Bainey KR. The interplay between cholesterol and breast cancer: is there a potential role for statin therapy?. Future Oncol. 2018 Aug;14(19):1885-1888. doi: 10.2217/fon-2018-0160. Epub 2018 Jul 27.
  • Pencina MJ, Rockhold FW, D’Agostino RB Sr. Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue. Ann Intern Med. 2018 Sep 18;169(6):401-402. doi: 10.7326/M18-1093. Epub 2018 Jul 24.
  • Kerneis M, Yee MK, Gibson CM. SECURE PCI: how important can a subgroup analysis be?. J Thorac Dis. 2018 Jun;10(Suppl 17):S2032-S2034. doi: 10.21037/jtd.2018.05.155.
  • Reynolds MR, Zheng Q, Doros G. Laser balloon ablation for AF: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2018 Oct;29(10):1363-1370. doi: 10.1111/jce.13698. Epub 2018 Aug 23.
  • Chen X, Porto CL, Chen Z, Merenda A, Allioux FM, d’Agostino R, Magniez K, Dai XJ, Palumbo F, Dumée LF. Single step synthesis of Janus nano-composite membranes by atmospheric aerosol plasma polymerization for solvents separation. Sci Total Environ. 2018 Dec 15;645:22-33. doi: 10.1016/j.scitotenv.2018.06.343. Epub 2018 Jul 14.
  • Green JB, Hernandez AF, D’Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV. Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. Am Heart J. 2018 Sep;203:30-38. doi: 10.1016/j.ahj.2018.03.030. Epub 2018 Jun 12.
  • Chi G, Kerneis M, Kalayci A, Liu Y, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. Am Heart J. 2018 Sep;203:17-24. doi: 10.1016/j.ahj.2018.06.003. Epub 2018 Jun 13.
  • Rosenson RS, Hegele RA, Fazio S, Cannon CP. The Evolving Future of PCSK9 Inhibitors. J Am Coll Cardiol. 2018 Jul 17;72(3):314-329. doi: 10.1016/j.jacc.2018.04.054. Epub 2018 Jul 9.
  • Cutlip DE, Fischman DL. Mortality After Percutaneous Coronary Intervention: Narrowing the Knowledge Gap. Circ Cardiovasc Interv. 2018 Jul;11(7):e007008. doi: 10.1161/CIRCINTERVENTIONS.118.007008.
  • Heiferman DM, Souter JR, Reynolds MR, Anderson DE, Serrone JC. Extracranial-to-Intracranial Bypass for Pressor Dependent Cerebrovascular Insufficiency: Modified Classification and Representative Case. Curr Neurovasc Res. 2018;15(3):256-261. doi: 10.2174/1567202615666180712155028.
  • Secemsky EA, Shen C, Yeh RW. Exposure Misclassification in Observational Studies: Setting New Standards. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004939. doi: 10.1161/CIRCOUTCOMES.118.004939.
  • Tarantino V, Savaia V, D’Agostino R, Silvestri M, Ciprandi G. Bacteriotherapy for preventing recurrent upper respiratory infections in children: a real-world experience. Otolaryngol Pol. 2018 May 16;72(3):33-38. doi: 10.5604/01.3001.0012.0482.
  • Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D’Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee. J Am Heart Assoc. 2018 Jul 7;7(14):e008426. doi: 10.1161/JAHA.117.008426.
  • Goldfarb M, Lauck S, Webb JG, Asgar AW, Perrault LP, Piazza N, Martucci G, Lachapelle K, Noiseux N, Kim DH, Popma JJ, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Morais JA, Morin JF, Rudski LG, Afilalo J. Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement. Circulation. 2018 Nov 13;138(20):2202-2211. doi: 10.1161/CIRCULATIONAHA.118.033887.
  • Gibson CM, Levitan B, Gibson WJ, Yee MK, Murphy SA, Yuan Z, Chakrabarti AK, Lee M, Braunwald E. Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome. J Am Coll Cardiol. 2018 Jul 10;72(2):129-136. doi: 10.1016/j.jacc.2018.04.055.
  • Capodanno D, Mehran R, Valgimigli M, Baber U, Windecker S, Vranckx P, Dangas G, Rollini F, Kimura T, Collet JP, Gibson CM, Steg PG, Lopes RD, Gwon HC, Storey RF, Franchi F, Bhatt DL, Serruys PW, Angiolillo DJ. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nat Rev Cardiol. 2018 Aug;15(8):480-496. doi: 10.1038/s41569-018-0049-1.
  • Gibson CM. Moving From Hope to Hard Work in Data Sharing. JAMA Cardiol. 2018 Sep 1;3(9):795-796. doi: 10.1001/jamacardio.2018.0130.
  • Mihatov N, Secemsky EA, Elmariah S. Triple Therapy: When, if Ever?. Curr Treat Options Cardiovasc Med. 2018 Jul 3;20(7):61. doi: 10.1007/s11936-018-0639-6.
  • Tripathi A, Flaherty MP, Abbott JD, Fonarow GC, Khan AR, Saraswat A, Chahil H, Kolte D, Elmariah S, Hirsch GA, Mathew V, Kirtane AJ, Bhatt DL. Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study). Am J Cardiol. 2018 Aug 1;122(3):431-439. doi: 10.1016/j.amjcard.2018.04.024. Epub 2018 May 8.
  • Secemsky EA, Yeh RW. Re: Multivessel Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction with Cardiogenic Shock. Epidemiology. 2018 Nov;29(6):e59-e60. doi: 10.1097/EDE.0000000000000884.
  • Leshchinskiy S, Ali N, D’Agostino R. Cobblestone sign. Abdom Radiol (NY). 2018 Dec;43(12):3532-3533. doi: 10.1007/s00261-018-1661-6.
  • Secemsky EA, Rosenfield K, Kennedy KF, Jaff M, Yeh RW. High Burden of 30-Day Readmissions After Acute Venous Thromboembolism in the United States. J Am Heart Assoc. 2018 Jun 26;7(13):e009047. doi: 10.1161/JAHA.118.009047.
  • Chi G, Yee MK, Kalayci A, Kerneis M, AlKhalfan F, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis. 2018 Oct;46(3):346-350. doi: 10.1007/s11239-018-1703-5.
  • Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR Jr, Harrington RA, Mahaffey KW; CHAMPION PLATFORM and CHAMPION PCI Investigators. Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials. Int J Cardiol. 2018 Nov 1;270:96-101. doi: 10.1016/j.ijcard.2018.06.034. Epub 2018 Jun 8.
  • Kolte D, Khera S, Vemulapalli S, Dai D, Heo S, Goldsweig AM, Aronow HD, Elmariah S, Inglessis I, Palacios IF, Thourani VH, Sharaf BL, Gordon PC, Abbott JD. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2018 Jun 25;11(12):1175-1185. doi: 10.1016/j.jcin.2018.03.002. Epub 2018 Mar 11.
  • Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Fail. 2018 Oct;5(5):772-779. doi: 10.1002/ehf2.12308. Epub 2018 Jun 19.
  • Vardeny O, Udell JA, Joseph J, Farkouh ME, Hernandez AF, McGeer AJ, Talbot HK, Bhatt DL, Cannon CP, Goodman SG, Anand I, DeMets DL, Temte J, Wittes J, Nichol K, Yancy CW, Gaziano JM, Cooper LS, Kim K, Solomon SD. High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial. Am Heart J. 2018 Aug;202:97-103. doi: 10.1016/j.ahj.2018.05.007. Epub 2018 May 23.
  • Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D’Agostino R Jr, Loo RK, Aaronson DS, Horwitz RI, Jacobsen SJ. The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep;119:70-78. doi: 10.1016/j.urology.2018.05.033. Epub 2018 Jun 12.
  • Simon TG, Corey KE, Cannon CP, Blazing M, Park JG, O’Donoghue ML, Chung RT, Giugliano RP. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018 Nov 1;270:245-252. doi: 10.1016/j.ijcard.2018.05.087. Epub 2018 May 26.
  • Lubitz SA, Khurshid S, Weng LC, Doros G, Keach JW, Gao Q, Gehi AK, Hsu JC, Reynolds MR, Turakhia MP, Maddox TM. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk. Am Heart J. 2018 Jun;200:24-31. doi: 10.1016/j.ahj.2018.03.003. Epub 2018 Mar 10.
  • Turchin A, Sosina O, Zhang H, Shubina M, Desai SP, Simonson DC, Testa MA. Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients With Diabetes. Diabetes Care. 2018 Aug;41(8):1639-1645. doi: 10.2337/dc17-1260. Epub 2018 Jun 11.
  • Bohula EA, Wiviott SD, Giugliano RP, Park JG, Murphy SA, Cannon CP, Braunwald E. Response by Bohula et al to Letters Regarding Article, “Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)”. Circulation. 2018 Jun 12;137(24):2662-2663. doi: 10.1161/CIRCULATIONAHA.118.034500.
  • McCarthy CP, Vaduganathan M, Januzzi JL Jr. Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment. JAMA. 2018 Aug 7;320(5):433-434. doi: 10.1001/jama.2018.7125.
  • McCarthy CP, Ibrahim NE, van Kimmenade RRJ, Gaggin HK, Simon ML, Gandhi P, Kelly N, Motiwala SR, Mukai R, Magaret CA, Barnes G, Rhyne RF, Garasic JM, Januzzi JL Jr. A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul;41(7):903-909. doi: 10.1002/clc.22939. Epub 2018 Jun 14.
  • Ravikanth R, Mathew S, Pinto DS. Management of acquired bronchopleural fistula due to chemical pneumonia. Ci Ji Yi Xue Za Zhi. 2018 Apr-Jun;30(2):116-118. doi: 10.4103/tcmj.tcmj_98_17.
  • Baber U, Li SX, Pinnelas R, Pocock SJ, Krucoff MW, Ariti C, Gibson CM, Steg PG, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Iakovou I, Dangas G, Aquino MB, Sartori S, Chieffo A, Moliterno DJ, Colombo A, Mehran R. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients). Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.
  • Baron SJ, Thourani VH, Kodali S, Arnold SV, Wang K, Magnuson EA, Pichard AD, Babaliaros V, George I, Miller DC, Tuzcu EM, Greason K, Herrmann HC, Smith CR, Leon MB, Cohen DJ; PARTNER 2 Investigators. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. JACC Cardiovasc Interv. 2018 Jun 25;11(12):1188-1198. doi: 10.1016/j.jcin.2018.02.032. Epub 2018 May 30.
  • Scirica BM, Bansilal S, Davoudi F, Armstrong PW, Clare RM, Schulte PJ, Pieper KS, Becker RC, James SK, Storey RF, Steg PG, Held C, Himmelmann A, Mahaffey KW, Wallentin L, Cannon CP; PLATO Steering Committee and Investigators. Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis. Am Heart J. 2018 Aug;202:54-60. doi: 10.1016/j.ahj.2018.04.020. Epub 2018 May 7.
  • Malmasi S, Hosomura N, Chang LS, Brown CJ, Skentzos S, Turchin A. Extracting Healthcare Quality Information from Unstructured Data. AMIA Annu Symp Proc. 2018 Apr 16;2017:1243-1252. eCollection 2017.
  • Jarolim P, White WB, Cannon CP, Gao Q, Morrow DA. Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial. Diabetes Care. 2018 Jul;41(7):1510-1515. doi: 10.2337/dc18-0109. Epub 2018 May 30.
  • Dmitrienko A, D’Agostino RB Sr. Multiplicity Considerations in Clinical Trials. N Engl J Med. 2018 May 31;378(22):2115-2122. doi: 10.1056/NEJMra1709701.
  • Reynolds MR, Heiferman DM, Boucher AB, Serrone JC, Barrow DL, Dion JE. Fusiform dilatation of the internal carotid artery following childhood craniopharyngioma resection treated by endovascular flow diversion-A case report and literature review. J Clin Neurosci. 2018 Aug;54:143-145. doi: 10.1016/j.jocn.2018.05.006. Epub 2018 May 24.
  • Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23.
  • Lee S, Cannon CP. Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events. Curr Cardiol Rep. 2018 May 25;20(7):55. doi: 10.1007/s11886-018-0997-4.
  • Blumenthal DM, Valsdottir LR, Zhao Y, Shen C, Kirtane AJ, Pinto DS, Resnic FS, Maddox KEJ, Wasfy JH, Mehran R, Rosenfield K, Yeh RW. A Survey of Interventional Cardiologists’ Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention. JAMA Cardiol. 2018 Jul 1;3(7):629-634. doi: 10.1001/jamacardio.2018.1095.
  • Wadhera RK, Joynt Maddox KE, Yeh RW, Bhatt DL. Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo. JAMA Cardiol. 2018 Jul 1;3(7):635-640. doi: 10.1001/jamacardio.2018.0947.
  • McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL Jr, Bhatt DL, McEvoy JW. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 Jul 1;3(7):642-649. doi: 10.1001/jamacardio.2018.1086.
  • Reynolds MR. Defining an Isthmus for the Cost Effectiveness of Catheter Ablation for Ventricular Tachycardia Associated With Prior Myocardial Infarction. JACC Clin Electrophysiol. 2018 May;4(5):669-671. doi: 10.1016/j.jacep.2018.03.004.
  • Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M, Hsieh WH, Sutherland J, Cannon CP. A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial. JACC Clin Electrophysiol. 2018 May;4(5):580-588. doi: 10.1016/j.jacep.2017.11.005. Epub 2017 Dec 20.
  • Ginsberg HN, Farnier M, Robinson JG, Cannon CP, Sattar N, Baccara-Dinet MT, Letierce A, Bujas-Bobanovic M, Louie MJ, Colhoun HM. Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies. Diabetes Ther. 2018 Jun;9(3):1317-1334. doi: 10.1007/s13300-018-0439-8. Epub 2018 May 19.
  • Scholtz JE, Addison D, Bittner DO, Janjua S, Foldyna B, Hedgire S, Staziaki PV, Januzzi JL Jr, Nagurney JT, Meyersohn N, Lu MT, Neilan TG, Hoffmann U, Ghoshhajra BB. Diagnostic Performance of Coronary CTA in Intermediate-to-High-Risk Patients for Suspected Acute Coronary Syndrome: Results From an Emergency Department Registry. JACC Cardiovasc Imaging. 2018 Sep;11(9):1369-1371. doi: 10.1016/j.jcmg.2018.03.014. Epub 2018 May 16.
  • Feldman DN, Weinberger J, Elmariah S. Device Closure of Patent Foramen Ovale in Patients With Cryptogenic Stroke: The Tide Has Turned. J Am Coll Cardiol. 2018 May 22;71(20):2343-2345. doi: 10.1016/j.jacc.2018.03.460.
  • Sharma A, Cannon CP, White WB, Liu Y, Bakris GL, Cushman WC, Zannad F. Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial. J Am Heart Assoc. 2018 May 16;7(11):e007649. doi: 10.1161/JAHA.117.007649.
  • Januzzi JL Jr, Richards AM. Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study. Circulation. 2018 May 15;137(20):2101-2103. doi: 10.1161/CIRCULATIONAHA.118.033853.
  • Brinkley DM Jr, Ho KKL, Drazner MH, Kociol RD. The prognostic value of the relationship between right atrial and pulmonary capillary wedge pressure in diverse cardiovascular conditions. Am Heart J. 2018 May;199:31-36. doi: 10.1016/j.ahj.2018.01.006. Epub 2018 Jan 31.
  • Januzzi JL, Butler J, Fombu E, Maisel A, McCague K, Piña IL, Prescott MF, Riebman JB, Solomon S. Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF). Am Heart J. 2018 May;199:130-136. doi: 10.1016/j.ahj.2017.12.021. Epub 2018 Feb 13.
  • Ibrahim NE, Song Y, Cannon CP, Doros G, Trebnick A, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr. Retraction notice to Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry® [International Journal of Cardiology 254 (2018) 222-223]. Int J Cardiol. 2018 Mar 1;254:R1. doi: 10.1016/j.ijcard.2018.05.008.
  • Wadhera RK, Shen C, Secemsky EA, Strom JB, Yeh RW. State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures. JACC Cardiovasc Interv. 2018 May 14;11(9):912-913. doi: 10.1016/j.jcin.2018.03.039.
  • Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, Armstrong PW, Van de Werf F, Montalescot G, Moliterno DJ, Held C, Aylward PE, Wallentin L, Harrington RA, Braunwald E, Mahaffey KW, White HD. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2018 May 14;11(9):856-864. doi: 10.1016/j.jcin.2018.02.006.
  • Spitzer E, McFadden E, Vranckx P, de Vries T, Ren B, Collet C, Onuma Y, Garcia-Garcia HM, Lopes RD, Stone GW, Cutlip DE, Serruys PW. Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. JACC Cardiovasc Interv. 2018 May 14;11(9):823-832. doi: 10.1016/j.jcin.2018.03.044.
  • Ardati AK, Cohen DJ. Transradial Percutaneous Coronary Intervention… Works Great! Less Billing!. Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004667. doi: 10.1161/CIRCOUTCOMES.118.004667.
  • Leshchinskiy S, Ali N, D’Agostino R. The small bowel “aneurysm”. Abdom Radiol (NY). 2018 Dec;43(12):3503-3504. doi: 10.1007/s00261-018-1605-1.
  • Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS; CHAMPION PHOENIX ECONOMICS Investigators. Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study. Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E348-E355. doi: 10.1002/ccd.27638. Epub 2018 May 4.
  • Bergmark BA, Udell JA, Morrow DA, Cannon CP, Steen DL, Jarolim P, Budaj A, Hamm C, Guo J, Im K, Kuder JF, Braunwald E, Sabatine MS, O’Donoghue ML. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2018 Jun 1;3(6):473-480. doi: 10.1001/jamacardio.2018.0653.
  • Gordon LB, Shappell H, Massaro J, D’Agostino RB Sr, Brazier J, Campbell SE, Kleinman ME, Kieran MW. Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome. JAMA. 2018 Apr 24;319(16):1687-1695. doi: 10.1001/jama.2018.3264.
  • Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES. The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335. doi: 10.1016/j.jcin.2018.02.036. Epub 2018 Apr 26.
  • Gibson CM, Elrod S. Students’ versus residency programs’ perceptions of a high-quality PGY1 residency applicant. Curr Pharm Teach Learn. 2018 Feb;10(2):137-145. doi: 10.1016/j.cptl.2017.10.006. Epub 2017 Oct 19.
  • Campa MF, Techtmann SM, Gibson CM, Zhu X, Patterson M, Garcia de Matos Amaral A, Ulrich N, Campagna SR, Grant CJ, Lamendella R, Hazen TC. Impacts of Glutaraldehyde on Microbial Community Structure and Degradation Potential in Streams Impacted by Hydraulic Fracturing. Environ Sci Technol. 2018 May 15;52(10):5989-5999. doi: 10.1021/acs.est.8b00239. Epub 2018 Apr 30.
  • Rogers T, Waksman R, Harrison JK, Deeb GM, Zhang AQ, Hermiller JB Jr, Popma JJ, Reardon MJ. Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. Am J Cardiol. 2018 Jun 1;121(11):1358-1364. doi: 10.1016/j.amjcard.2018.02.008. Epub 2018 Mar 1.
  • Golwala HB, Cannon CP, Steg PG, Doros G, Qamar A, Ellis SG, Oldgren J, Ten Berg JM, Kimura T, Hohnloser SH, Lip GYH, Bhatt DL. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.
  • Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, Younes A, Walia SS, Pitliya A, Singh A, Kahe F, Kalayci A, Nafee T, Kerneis M, AlKhalfan F, Cohen AT, Harrington RA, Goldhaber SZ. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. Am J Med. 2018 Aug;131(8):972.e1-972.e7. doi: 10.1016/j.amjmed.2018.03.031. Epub 2018 Apr 13.
  • Whelton SP, Mauer AC, Pencina KM, Massaro JM, D’Agostino RB, Fox CS, Hoffmann U, Michos ED, Peloso GM, Dufresne L, Engert JC, Kathiresan S, Budoff M, Post WS, Thanassoulis G, O’Donnell CJ. Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium. Am J Cardiol. 2018 May 15;121(10):1246-1252. doi: 10.1016/j.amjcard.2018.01.048. Epub 2018 Feb 13.
  • Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, Brass N, Armstrong PW, Kaul P. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol. 2018 Aug 1;264:12-17. doi: 10.1016/j.ijcard.2018.04.004. Epub 2018 Apr 4.
  • Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Yeh RW. 30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries. JACC Heart Fail. 2018 May;6(5):379-387. doi: 10.1016/j.jchf.2017.11.010. Epub 2018 Apr 11.
  • Inagaki E, Farber A, Siracuse JJ, Mell MW, Rybin DV, Doros G, Kalish J; Vascular Quality Initiative. Routine Use of Ultrasound Guidance in Femoral Arterial Access for Peripheral Vascular Intervention Decreases Groin Hematoma Rates in High-Volume Surgeons. Ann Vasc Surg. 2018 Aug;51:1-7. doi: 10.1016/j.avsg.2018.02.008. Epub 2018 Apr 13.
  • Gibson CM, Nafee T, Yee MK, Chi G, Korjian S, Daaboul Y, AlKhalfan F, Kerneis M, Goldhaber SZ, Hull R, Hernandez AF, Cohen AT, Harrington RA. Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. Am Heart J. 2018 Apr;198:84-90. doi: 10.1016/j.ahj.2017.12.015. Epub 2017 Dec 27.
  • Cavender MA, White WB, Liu Y, Massaro JM, Bergenstal RM, Mehta CR, Zannad F, Heller S, Cushman WC, Cannon CP. Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome. Clin Cardiol. 2018 Aug;41(8):1022-1027. doi: 10.1002/clc.22960. Epub 2018 Aug 16.
  • Kaadan MI, MacDonald C, Ponzini F, Duran J, Newell K, Pitler L, Lin A, Weinberg I, Wood MJ, Lindsay ME. Prospective Cardiovascular Genetics Evaluation in Spontaneous Coronary Artery Dissection. Circ Genom Precis Med. 2018 Apr;11(4):e001933. doi: 10.1161/CIRCGENETICS.117.001933.
  • Yeh RW. Academic Cardiology and Social Media: Navigating the Wisdom and Madness of the Crowd. Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004736. doi: 10.1161/CIRCOUTCOMES.118.004736.
  • Inagaki E, Farber A, Kalish JA, Eslami MH, Siracuse JJ, Eberhardt RT, Rybin DV, Doros G, Hamburg NM; Vascular Study Group of New England. Outcomes of Peripheral Vascular Interventions in Select Patients With Lower Extremity Acute Limb Ischemia. J Am Heart Assoc. 2018 Apr 12;7(8):e004782. doi: 10.1161/JAHA.116.004782.
  • Gupta T, Khera S, Kolte D, Goel K, Kalra A, Villablanca PA, Aronow HD, Abbott JD, Fonarow GC, Taub CC, Kleiman NS, Weisz G, Inglessis I, Elmariah S, Rihal CS, Garcia MJ, Bhatt DL. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes. Circ Cardiovasc Interv. 2018 Apr;11(4):e006179. doi: 10.1161/CIRCINTERVENTIONS.117.006179.
  • Cigarroa R, Elmariah S. Anticoagulation Management After Transcatheter and Surgical Valve Replacement. Curr Treat Options Cardiovasc Med. 2018 Apr 11;20(5):42. doi: 10.1007/s11936-018-0629-8.
  • D’Agostino R, Ali NS, Leshchinskiy S, Cherukuri AR, Tam JK. Small bowel obstruction and the gastrografin challenge. Abdom Radiol (NY). 2018 Nov;43(11):2945-2954. doi: 10.1007/s00261-018-1591-3.
  • Groves EM, Bhatt DL, Steg PG, Deliargyris EN, Stone GW, Gibson CM, Hamm CW, Mahaffey KW, White HD, Angiolillo DJ, Prats J, Harrington RA, Price MJ. Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). Circ Cardiovasc Interv. 2018 Apr;11(4):e005635. doi: 10.1161/CIRCINTERVENTIONS.117.005635.
  • Jiang J, Thalamuthu A, Ho JE, Mahajan A, Ek WE, Brown DA, Breit SN, Wang TJ, Gyllensten U, Chen MH, Enroth S, Januzzi JL Jr, Lind L, Armstrong NJ, Kwok JB, Schofield PR, Wen W, Trollor JN, Johansson Å, Morris AP, Vasan RS, Sachdev PS, Mather KA. A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in Blood. Front Genet. 2018 Mar 23;9:97. doi: 10.3389/fgene.2018.00097. eCollection 2018.
  • Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW. Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval. Am J Cardiol. 2018 Jun 1;121(11):1365-1372. doi: 10.1016/j.amjcard.2018.02.016. Epub 2018 Mar 1.
  • Celano CM, Albanese AM, Millstein RA, Mastromauro CA, Chung WJ, Campbell KA, Legler SR, Park ER, Healy BC, Collins LM, Januzzi JL, Huffman JC. Optimizing a Positive Psychology Intervention to Promote Health Behaviors After an Acute Coronary Syndrome: The Positive Emotions After Acute Coronary Events III (PEACE-III) Randomized Factorial Trial. Psychosom Med. 2018 Jul/Aug;80(6):526-534. doi: 10.1097/PSY.0000000000000584.
  • Rubin DJ, Recco D, Turchin A, Zhao H, Golden SH. EXTERNAL VALIDATION OF THE DIABETES EARLY RE-ADMISSION RISK INDICATOR (DERRI(™)). Endocr Pract. 2018 Jun;24(6):527-541. doi: 10.4158/EP-2018-0035. Epub 2018 Apr 6.
  • Ali N, Leshchinskiy S, Johnson M, D’Agostino R. The sentinel loop sign. Abdom Radiol (NY). 2018 Nov;43(11):3192-3194. doi: 10.1007/s00261-018-1582-4.
  • Okada K, Honda Y, Kitahara H, Otagiri K, Tanaka S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators. Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial. JACC Cardiovasc Interv. 2018 Apr 9;11(7):648-661. doi: 10.1016/j.jcin.2017.11.034.
  • Eslami MH, Reitz KM, Rybin DV, Doros G, Farber A. Improved access to health care in Massachusetts after 2006 Massachusetts Healthcare Reform Law is associated with a significant decrease in mortality among vascular surgery patients. J Vasc Surg. 2018 Oct;68(4):1193-1202.e1. doi: 10.1016/j.jvs.2017.12.066. Epub 2018 Mar 31.
  • Foldyna B, Troschel FM, Addison D, Fintelmann FJ, Elmariah S, Furman D, Eslami P, Ghoshhajra B, Lu MT, Murthy VL, Hoffmann U, Shah R. Computed tomography-based fat and muscle characteristics are associated with mortality after transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2018 May-Jun;12(3):223-228. doi: 10.1016/j.jcct.2018.03.007. Epub 2018 Mar 22.
  • Felker GM, Januzzi JL Jr. “Time Is Muscle” in Acute Heart Failure: Critical Concept or Fake News?. JACC Heart Fail. 2018 Apr;6(4):295-297. doi: 10.1016/j.jchf.2018.01.011.
  • Faridi KF, Yeh RW. Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy. BMJ Evid Based Med. 2018 Apr;23(2):73-74. doi: 10.1136/bmjebm-2017-110822. Epub 2018 Feb 19.
  • Saxon JT, Allen KB, Cohen DJ, Chhatriwalla AK. Bioprosthetic Valve Fracture During Valve-in-valve TAVR: Bench to Bedside. Interv Cardiol. 2018 Jan;13(1):20-26. doi: 10.15420/icr.2017:29:1.
  • Secemsky EA, Yeh RW. Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival-The Key Is Immortality. JAMA Cardiol. 2018 May 1;3(5):443-444. doi: 10.1001/jamacardio.2018.0078.
  • Butala NM, Kramer DB, Shen C, Strom JB, Kennedy KF, Wang Y, Valsdottir LR, Wasfy JH, Yeh RW. Applicability of Publicly Reported Hospital Readmission Measures to Unreported Conditions and Other Patient Populations: A Cross-sectional All-Payer Study. Ann Intern Med. 2018 May 1;168(9):631-639. doi: 10.7326/M17-1492. Epub 2018 Mar 27.
  • White WB, Heller SR, Cannon CP, Howitt H, Khunti K, Bergenstal RM; EXAMINE Investigators. Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial. Am J Med. 2018 Jul;131(7):813-819.e5. doi: 10.1016/j.amjmed.2018.02.023. Epub 2018 Mar 23.
  • Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D’Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP. External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction. Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.
  • Hajovsky DB, Villeneuve EF, Reynolds MR, Niileksela CR, Mason BA, Shudak NJ. Cognitive ability influences on written expression: Evidence for developmental and sex-based differences in school-age children. J Sch Psychol. 2018 Apr;67:104-118. doi: 10.1016/j.jsp.2017.09.001. Epub 2017 Sep 18.
  • Zhang H, Plutzky J, Ge W, Shubina M, Turchin A. Predictors of a successful statin reattempt after an adverse reaction. J Clin Lipidol. 2018 May-Jun;12(3):643-651. doi: 10.1016/j.jacl.2018.02.005. Epub 2018 Feb 14.
  • Arnold SV, O’Brien SM, Vemulapalli S, Cohen DJ, Stebbins A, Brennan JM, Shahian DM, Grover FL, Holmes DR, Thourani VH, Peterson ED, Edwards FH; STS/ACC TVT Registry. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2018 Mar 26;11(6):581-589. doi: 10.1016/j.jcin.2018.01.242.
  • Gibson CM, Hankey GJ, Nafee T, Welsh RC. Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban. Thromb Haemost. 2018 May;118(S 01):S34-S44. doi: 10.1055/s-0038-1635086. Epub 2018 Mar 22.
  • Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Fox KAA, Cohen M. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. JACC Cardiovasc Interv. 2018 Apr 9;11(7):626-634. doi: 10.1016/j.jcin.2017.11.009. Epub 2018 Mar 14.
  • Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Rivers EJ, Walters EL, Gaggin HK; ICON-RELOADED Investigators. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021.
  • de Boer IH, Bakris G, Cannon CP. Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations. JAMA. 2018 Apr 3;319(13):1319-1320. doi: 10.1001/jama.2018.0642.
  • Cavallari I, Cannon CP, Braunwald E, Goodrich EL, Im K, Lukas MA, O’Donoghue ML. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. Eur J Prev Cardiol. 2018 May;25(8):830-838. doi: 10.1177/2047487318763897. Epub 2018 Mar 14.
  • Kandzari DE, Mauri L, Koolen JJ, Doros G, Waksman R. Bioresorbable polymer drug-eluting stents – Authors’ reply. Lancet. 2018 Mar 10;391(10124):936-937. doi: 10.1016/S0140-6736(18)30535-X.
  • DeFilippis EM, Singh A, Divakaran S, Gupta A, Collins BL, Biery D, Qamar A, Fatima A, Ramsis M, Pipilas D, Rajabi R, Eng M, Hainer J, Klein J, Januzzi JL, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2018 Jun 5;71(22):2540-2551. doi: 10.1016/j.jacc.2018.02.047. Epub 2018 Mar 10.
  • Greene SJ, Vaduganathan M, Khan MS, Bakris GL, Weir MR, Seltzer JH, Sattar N, McGuire DK, Januzzi JL, Stockbridge N, Butler J. Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes. J Am Coll Cardiol. 2018 Mar 27;71(12):1379-1390. doi: 10.1016/j.jacc.2018.01.047. Epub 2018 Mar 10.
  • Mansell SK, Cutts S, Hackney I, Wood MJ, Hawksworth K, Creer DD, Kilbride C, Mandal S. Using domiciliary non-invasive ventilator data downloads to inform clinical decision-making to optimise ventilation delivery and patient compliance. BMJ Open Respir Res. 2018 Mar 3;5(1):e000238. doi: 10.1136/bmjresp-2017-000238. eCollection 2018.
  • Jennings-Gee J, Quataert S, Ganguly T, D’Agostino R Jr, Deora R, Dubey P. The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs. Infect Immun. 2018 May 22;86(6):e00935-17. doi: 10.1128/IAI.00935-17. Print 2018 Jun.
  • Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Bhatt DL, Yeh RW. Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004397. doi: 10.1161/CIRCOUTCOMES.117.004397.
  • Austin PC, Lee DS, D’Agostino RB, Fine JP. Developing points-based risk-scoring systems in the presence of competing risks. Stat Med. 2018 Apr 15;37(8):1405. doi: 10.1002/sim.7591. Epub 2017 Dec 18.
  • Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018 Jun;93(6):1397-1408. doi: 10.1016/j.kint.2017.12.011. Epub 2018 Mar 8.
  • Jena AB, Olenski A, Blumenthal DM, Yeh RW, Goldman DP, Romley J. Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings. J Am Heart Assoc. 2018 Mar 9;7(6):e008230. doi: 10.1161/JAHA.117.008230.
  • Udell JA, Fonarow GC, Maddox TM, Cannon CP, Frank Peacock W, Laskey WK, Grau-Sepulveda MV, Smith EE, Hernandez AF, Peterson ED, Bhatt DL; Get With The Guidelines Steering Committee and Investigators. Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry. Clin Cardiol. 2018 Jun;41(6):758-768. doi: 10.1002/clc.22938. Epub 2018 May 11.
  • Bunte MC, Cohen DJ, Jaff MR, Gray WA, Magnuson EA, Li H, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Patarca R, Du J, Stoll HP, Massaro J, Safley DM; STROLL Study Investigators. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study. Catheter Cardiovasc Interv. 2018 Jul;92(1):106-114. doi: 10.1002/ccd.27569. Epub 2018 Mar 9.
  • McCarthy CP, Ibrahim NE, Lyass A, Li Y, Gaggin HK, Simon ML, Mukai R, Gandhi P, Kelly N, Motiwala SR, van Kimmenade RRJ, Massaro JM, D’Agostino RB Sr, Januzzi JL Jr. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study. J Am Heart Assoc. 2018 Mar 8;7(6):e007975. doi: 10.1161/JAHA.117.007975.
  • Baum SJ, Cannon CP. PCSK9 inhibitor valuation: A science-based review of the two recent models. Clin Cardiol. 2018 Apr;41(4):544-550. doi: 10.1002/clc.22924. Epub 2018 Mar 7.
  • Leshchinskiy S, Ali N, D’Agostino R. The inlet patch. Abdom Radiol (NY). 2018 Oct;43(10):2882-2884. doi: 10.1007/s00261-018-1532-1.
  • Januzzi JL Jr. Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials?. JACC Heart Fail. 2018 Jul;6(7):570-572. doi: 10.1016/j.jchf.2018.02.008. Epub 2018 Mar 4.
  • Daaboul Y, Korjian S, Plotnikov AN, Burton P, Braunwald E, Wiviott SD, Gibson CM. Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2018 Mar 6;71(9):1048-1049. doi: 10.1016/j.jacc.2017.12.045.
  • Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O’Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ; Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J Am Coll Cardiol. 2018 Mar 6;71(9):1021-1034. doi: 10.1016/j.jacc.2017.12.048.
  • Torina A, Blanda V, Blanda M, Auteri M, La Russa F, Scimeca S, D’Agostino R, Disclafani R, Villari S, Currò V, Caracappa S. A Geographical Information System Based Approach for Integrated Strategies of Tick Surveillance and Control in the Peri-Urban Natural Reserve of Monte Pellegrino (Palermo, Southern Italy). Int J Environ Res Public Health. 2018 Feb 27;15(3):404. doi: 10.3390/ijerph15030404.
  • Danek BA, Basir MB, O’Neill WW, Alqarqaz M, Karatasakis A, Karmpaliotis D, Jaffer FA, Yeh RW, Wyman M, Lombardi WL, Kandzari D, Lembo N, Doing A, Patel M, Mahmud E, Choi JW, Toma C, Moses JW, Kirtane A, Parikh M, Ali ZA, Garcia S, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES, Alaswad K. Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry. J Invasive Cardiol. 2018 Mar;30(3):81-87.
  • Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O’Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ; Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018 Feb 27;137(9):961-972. doi: 10.1161/CIRCULATIONAHA.117.033502.
  • Lau ES, Wood MJ. How do we attract and retain women in cardiology?. Clin Cardiol. 2018 Feb;41(2):264-268. doi: 10.1002/clc.22921. Epub 2018 Feb 26.
  • Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19.
  • Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, Ganesh SK, Gulati R, Lindsay ME, Mieres JH, Naderi S, Shah S, Thaler DE, Tweet MS, Wood MJ; American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation. 2018 May 8;137(19):e523-e557. doi: 10.1161/CIR.0000000000000564. Epub 2018 Feb 22.
  • Kumar V, Gopalakrishnan L, Singh M, Singh S, Kovacs DF, Benatar D, Gibson CM, Khosla S. Effect of Cocaine on Coronary Microvasculature. J Am Coll Cardiol. 2018 Feb 27;71(8):954-955. doi: 10.1016/j.jacc.2017.12.030.
  • Ibrahim NE, Januzzi JL Jr. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study. Curr Heart Fail Rep. 2018 Apr;15(2):37-43. doi: 10.1007/s11897-018-0381-0.
  • Prakash A, Gordon LB, Kleinman ME, Gurary EB, Massaro J, D’Agostino R Sr, Kieran MW, Gerhard-Herman M, Smoot L. Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome. JAMA Cardiol. 2018 Apr 1;3(4):326-334. doi: 10.1001/jamacardio.2017.5235.
  • Leshchinskiy S, D’Agostino R. The coiled spring sign of appendiceal intussusception. Abdom Radiol (NY). 2018 Sep;43(9):2539-2541. doi: 10.1007/s00261-018-1506-3.
  • Ibrahim K, McCarthy CP, McCarthy KJ, Brown CH, Needham DM, Januzzi JL Jr, McEvoy JW. Delirium in the Cardiac Intensive Care Unit. J Am Heart Assoc. 2018 Feb 16;7(4):e008568. doi: 10.1161/JAHA.118.008568.
  • Kedev S, Zafirovska B, Antov S, Kostov J, Spiroski I, Boshev M, Vasilev I, Jovkovski A, Taravari H, Kitanoski D, Petkoska D, Ho KKL. Total wrist access for angiography and interventions: Procedural success and access site crossover in a high volume transradial center. Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):570-574. doi: 10.1016/j.carrev.2017.12.009. Epub 2017 Dec 24.
  • Aggarwal NR, Patel HN, Mehta LS, Sanghani RM, Lundberg GP, Lewis SJ, Mendelson MA, Wood MJ, Volgman AS, Mieres JH. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps. Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004437. doi: 10.1161/CIRCOUTCOMES.117.004437.
  • Yang JX, Yeh RW. Safety and effectiveness of zotarolimus-eluting stents for percutaneous coronary intervention: a systematic review. Future Cardiol. 2018 May 1;14(3):251-267. doi: 10.2217/fca-2017-0091. Epub 2018 Feb 16.
  • Sherwood MW, Lopes RD, Sun JL, Liaw D, Harrington RA, Wallentin L, Laskowitz DT, James SK, Goodman SG, Darius H, Lewis BS, Gibson CM, Pieper KS, Alexander JH. Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial. Am Heart J. 2018 Mar;197:1-8. doi: 10.1016/j.ahj.2017.09.020. Epub 2017 Oct 24.
  • Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, D’Agostino RB Sr. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection. Circulation. 2018 May 22;137(21):2203-2214. doi: 10.1161/CIRCULATIONAHA.117.028975. Epub 2018 Feb 14.
  • Storey RF, Ardissino D, Vignali L, Cairns R, Becker RC, Cannon CP, Mahaffey KW, Himmelmann A, Katus HA, James SK, Wallentin L; PLATO Investigators. Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study. Thromb Haemost. 2018 Feb;118(2):427-429. doi: 10.1160/TH17-05-0355. Epub 2018 Jan 29.
  • Shah R, Ziegler O, Yeri A, Liu X, Murthy V, Rabideau D, Xiao CY, Hanspers K, Belcher A, Tackett M, Rosenzweig A, Pico AR, Januzzi JL, Das S. MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression. Circ Heart Fail. 2018 Feb;11(2):e004278. doi: 10.1161/CIRCHEARTFAILURE.117.004278.
  • Broussard CS, Shapiro-Mendoza CK, Peacock G, Rasmussen SA, Mai CT, Petersen EE, Galang RR, Newsome K, Reynolds MR, Gilboa SM, Boyle CA, Moore CA. Public Health Approach to Addressing the Needs of Children Affected by Congenital Zika Syndrome. Pediatrics. 2018 Feb;141(Suppl 2):S146-S153. doi: 10.1542/peds.2017-2038C.
  • Rosman NP, Vassar R, Doros G, DeRosa J, Froman A, DiMauro A, Santiago S, Abbott J. Association of Prenatal Ultrasonography and Autism Spectrum Disorder. JAMA Pediatr. 2018 Apr 1;172(4):336-344. doi: 10.1001/jamapediatrics.2017.5634.
  • Havasi A, Doros G, Sanchorawala V. Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation. Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24.
  • Little SH, Popma JJ, Kleiman NS, Deeb GM, Gleason TG, Yakubov SJ, Checuti S, O’Hair D, Bajwa T, Mumtaz M, Maini B, Hartman A, Katz S, Robinson N, Petrossian G, Heiser J, Merhi W, Moore BJ, Li S, Adams DH, Reardon MJ. Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery. J Thorac Cardiovasc Surg. 2018 May;155(5):1991-1999. doi: 10.1016/j.jtcvs.2017.11.108. Epub 2018 Jan 31.
  • Mendoza JA, Haaland W, D’Agostino RB, Martini L, Pihoker C, Frongillo EA, Mayer-Davis EJ, Liu LL, Dabelea D, Lawrence JM, Liese AD. Food insecurity is associated with high risk glycemic control and higher health care utilization among youth and young adults with type 1 diabetes. Diabetes Res Clin Pract. 2018 Apr;138:128-137. doi: 10.1016/j.diabres.2018.01.035. Epub 2018 Feb 8.
  • Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.
  • Ibrahim NE, Lyass A, Gaggin HK, Liu Y, van Kimmenade RRJ, Motiwala SR, Kelly NP, Gandhi PU, Simon ML, Belcher AM, Harisiades JE, Massaro JM, D’Agostino RB, Januzzi JL Jr. Predicting new-onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. ESC Heart Fail. 2018 Jun;5(3):240-248. doi: 10.1002/ehf2.12268. Epub 2018 Feb 9.
  • Andreu Cayuelas JM, Caro Martínez C, Flores Blanco PJ, Elvira Ruiz G, Albendin Iglesias H, Cerezo Manchado JJ, Bailen Lorenzo JL, Januzzi JL, García Alberola A, Manzano-Fernández S. Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12907. doi: 10.1111/eci.12907. Epub 2018 Apr 22.
  • McCarthy CP, McEvoy JW, Januzzi JL Jr. Biomarkers in stable coronary artery disease. Am Heart J. 2018 Feb;196:82-96. doi: 10.1016/j.ahj.2017.10.016. Epub 2017 Oct 28.
  • Januzzi JL Jr, McCarthy CP. Evaluating Chest Pain in the Emergency Department: Searching for the Optimal Gatekeeper. J Am Coll Cardiol. 2018 Feb 13;71(6):617-619. doi: 10.1016/j.jacc.2017.11.065.
  • Vidula MK, Secemsky EA, Yeh RW. Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):491-499. doi: 10.1016/j.pcad.2018.01.006. Epub 2018 Feb 2.
  • Ibrahim NE, Song Y, Cannon CP, Doros G, Trebnick A, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr. Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®. Int J Cardiol. 2018 Mar 1;254:222-223. doi: 10.1016/j.ijcard.2017.10.096. Epub 2018 Jan 28.
  • Vodovar N, Mebazaa A, Januzzi JL Jr, Murtagh G, Stough WG, Adams KF Jr, Zannad F. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials. Int J Cardiol. 2018 Mar 1;254:215-221. doi: 10.1016/j.ijcard.2017.11.001. Epub 2018 Jan 28.
  • Bossard M, Lavi S, Rao SV, Cohen DJ, Cantor WJ, Bainey KR, Valettas N, Jolly SS, Mehta SR. Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns. Catheter Cardiovasc Interv. 2018 Nov 1;92(5):854-859. doi: 10.1002/ccd.27530. Epub 2018 Feb 6.
  • Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Yeh RW. National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention. 2018 Apr 6;13(18):e2152-e2159. doi: 10.4244/EIJ-D-17-00947.
  • Kerneis M, Talib U, Nafee T, Daaboul Y, Pahlavani S, Pitliya A, Furqan MM, Datta S, Kazmi HA, Younes A, Gibson CM. Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):524-530. doi: 10.1016/j.pcad.2018.01.008. Epub 2018 Feb 3.
  • Culler SD, Cohen DJ, Brown PP, Kugelmass AD, Reynolds MR, Ambrose K, Schlosser ML, Simon AW, Katz MR. Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has Transcatheter Aortic Valve Replacement Made a Difference?. Ann Thorac Surg. 2018 Apr;105(4):1137-1143. doi: 10.1016/j.athoracsur.2017.10.057. Epub 2018 Feb 1.
  • Blanda V, Blanda M, La Russa F, Scimeca R, Scimeca S, D’Agostino R, Auteri M, Torina A. Geo-statistical analysis of Culicoides spp. distribution and abundance in Sicily, Italy. Parasit Vectors. 2018 Feb 1;11(1):78. doi: 10.1186/s13071-018-2658-2.
  • Cannon CP, Lip GYH, Oldgren J. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2018 Feb 1;378(5):485-486. doi: 10.1056/NEJMc1715183.
  • Ko SQ, Strom JB, Shen C, Yeh RW. Mortality, Length of Stay, and Cost of Weekend Admissions. J Hosp Med. 2018 Jul 1;13(7):476-481. doi: 10.12788/jhm.2906. Epub 2018 Jan 25.
  • Effron MB, Gibson CM. The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):457-459. doi: 10.1016/j.pcad.2018.01.011. Epub 2018 Jan 31.
  • Effron MB, Gibson CM. Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy – “Real World” Experience. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):531-536. doi: 10.1016/j.pcad.2018.01.010. Epub 2018 Jan 31.
  • Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL 3rd, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovasc Interv. 2018 Jan 22;11(2):160-168. doi: 10.1016/j.jcin.2017.10.014.
  • Drudi LM, Ades M, Turkdogan S, Huynh C, Lauck S, Webb JG, Piazza N, Martucci G, Langlois Y, Perrault LP, Asgar AW, Labinaz M, Lamy A, Noiseux N, Peterson MD, Arora RC, Lindman BR, Bendayan M, Mancini R, Trnkus A, Kim DH, Popma JJ, Afilalo J. Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement. JAMA Cardiol. 2018 Mar 1;3(3):191-197. doi: 10.1001/jamacardio.2017.5064.
  • Mowakeaa S, Dwivedi A, Grossman JR, Parikh G, Curillova Z, Aragam KG, Elmariah S, Kinlay S, Aragam J. Prognosis of patients with secondary mitral regurgitation and reduced ejection fraction. Open Heart. 2018 Jan 9;5(1):e000745. doi: 10.1136/openhrt-2017-000745. eCollection 2018.
  • Kolachalama VB, Shashar M, Alousi F, Shivanna S, Rijal K, Belghasem ME, Walker J, Matsuura S, Chang GH, Gibson CM, Dember LM, Francis JM, Ravid K, Chitalia VC. Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans. J Am Soc Nephrol. 2018 Mar;29(3):1063-1072. doi: 10.1681/ASN.2017080929. Epub 2018 Jan 17.
  • Siracuse JJ, Farber A, Kalish JA, Jones DW, Rybin D, Doros G, Scali ST, Schermerhorn ML; Vascular Quality Initiative. Comparison of access type on perioperative outcomes after endovascular aortic aneurysm repair. J Vasc Surg. 2018 Jul;68(1):91-99. doi: 10.1016/j.jvs.2017.10.075. Epub 2018 Jan 17.
  • Mauri L, D’Agostino RB Sr. Noninferiority Trials. N Engl J Med. 2018 Jan 18;378(3):304-305. doi: 10.1056/NEJMc1714668.
  • Gordon LB, Campbell SE, Massaro JM, D’Agostino RB Sr, Kleinman ME, Kieran MW, Moses MA. Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib. Pediatr Res. 2018 May;83(5):982-992. doi: 10.1038/pr.2018.9. Epub 2018 Feb 28.
  • Zhang H, Mu L, Hu S, Nallamothu BK, Lansky AJ, Xu B, Bouras G, Cohen DJ, Spertus JA, Masoudi FA, Curtis JP, Gao R, Ge J, Yang Y, Li J, Li X, Zheng X, Li Y, Krumholz HM, Jiang L; China PEACE Collaborative Group. Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China. JAMA Intern Med. 2018 Feb 1;178(2):239-247. doi: 10.1001/jamainternmed.2017.7821.
  • Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):398-405. doi: 10.2215/CJN.05280517. Epub 2018 Jan 16.
  • Allen KB, Thourani VH, Naka Y, Grubb KJ, Grehan J, Patel N, Guy TS, Landolfo K, Gerdisch M, Bonnell M, Cohen DJ. Rigid Plate Fixation Versus Wire Cerclage: Patient-Reported and Economic Outcomes From a Randomized Trial. Ann Thorac Surg. 2018 May;105(5):1344-1350. doi: 10.1016/j.athoracsur.2017.12.011. Epub 2018 Jan 11.
  • Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Tang WHW, Grodin J, Passino C, Emdin M. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis. Circulation. 2018 Jan 16;137(3):286-297. doi: 10.1161/CIRCULATIONAHA.117.031560.
  • McCarthy CP, Januzzi JL Jr, Gaggin HK. Type 2 Myocardial Infarction – An Evolving Entity. Circ J. 2018 Jan 25;82(2):309-315. doi: 10.1253/circj.CJ-17-1399. Epub 2018 Jan 13.
  • Wadhera RK, Yeh RW, Joynt Maddox KE. The Rise and Fall of Mandatory Cardiac Bundled Payments. JAMA. 2018 Jan 23;319(4):335-336. doi: 10.1001/jama.2017.19205.
  • de Boer RA, Nayor M, deFilippi CR, Enserro D, Bhambhani V, Kizer JR, Blaha MJ, Brouwers FP, Cushman M, Lima JAC, Bahrami H, van der Harst P, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Shah SJ, Levy D, Herrington DM, Larson MG, van Gilst WH, Gottdiener JS, Bertoni AG, Ho JE. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction. JAMA Cardiol. 2018 Mar 1;3(3):215-224. doi: 10.1001/jamacardio.2017.4987.
  • Elmariah S, Doros G, Benavente OR, Bhatt DL, Connolly SJ, Yusuf S, Steinhubl SR, Liu Y, Hsieh WH, Yeh RW, Mauri L. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis. Circ Cardiovasc Interv. 2018 Jan;11(1):e005795. doi: 10.1161/CIRCINTERVENTIONS.117.005795.
  • Deeb GM, Chetcuti SJ, Yakubov SJ, Patel HJ, Grossman PM, Kleiman NS, Heiser J, Merhi W, Zorn GL 3rd, Tadros PN, Petrossian G, Robinson N, Mumtaz M, Gleason TG, Huang J, Conte JV, Popma JJ, Reardon MJ. Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018 Apr;105(4):1129-1136. doi: 10.1016/j.athoracsur.2017.08.059. Epub 2018 Jan 5.
  • Szerlip M, Gualano S, Holper E, Squiers JJ, White JM, Doshi D, Williams MR, Hahn RT, Webb JG, Svensson LG, Kirtane AJ, Cohen DJ, Douglas PS, Alu MC, Crowley A, Tuzcu EM, Makkar RR, Herrmann HC, Babaliaros V, Thourani VH, Leon MB, Kodali SK, Mack MJ. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. JACC Cardiovasc Interv. 2018 Jan 8;11(1):13-20. doi: 10.1016/j.jcin.2017.09.035.
  • Gibson CM, Nafee T, Kerneis M. Silent Myocardial Infarction: Listen to the Evidence. J Am Coll Cardiol. 2018 Jan 2;71(1):9-11. doi: 10.1016/j.jacc.2017.10.069.
  • Elmariah S, Farrell LA, Furman D, Lindman BR, Shi X, Morningstar JE, Rhee EP, Gerszten RE. Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2018 Mar 1;3(3):242-246. doi: 10.1001/jamacardio.2017.4873.
  • Salisbury AC, Sapontis J, Saxon JT, Gosch KL, Lombardi WL, Karmpaliotis D, Moses JW, Qintar M, Kirtane AJ, Spertus JA, Cohen DJ, Grantham JA. Association of Stress Test Risk Classification With Health Status After Chronic Total Occlusion Angioplasty (from the Outcomes, Patient Health Status and Efficiency in Chronic Total Occlusion Hybrid Procedures [OPEN-CTO] Study). Am J Cardiol. 2018 Mar 1;121(5):558-563. doi: 10.1016/j.amjcard.2017.11.024. Epub 2017 Dec 11.
  • Szujewski CC, Heiferman DM, Rosenbaum MD, Reynolds MR, Anderson DE, Serrone JC. Angiographic “Blush” After Stereotactic Radiosurgery Ablation of Residual Arteriovenous Malformation in Pediatric Patient: Case Report and Review of Literature. World Neurosurg. 2018 Mar;111:235-239. doi: 10.1016/j.wneu.2017.12.109. Epub 2017 Dec 27.
  • Steen DL, Umez-Eronini AA, Guo J, Khan N, Cannon CP. The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22. Clin Cardiol. 2018 Jan;41(1):68-73. doi: 10.1002/clc.22851. Epub 2017 Dec 28.
  • Leshchinskiy S, D’Agostino R. Hidebound bowel sign. Abdom Radiol (NY). 2018 Sep;43(9):2513-2516. doi: 10.1007/s00261-017-1445-4.
  • Chi G, Yee MK, Amin AN, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM. Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). Circulation. 2018 Jan 2;137(1):91-94. doi: 10.1161/CIRCULATIONAHA.117.031187.
  • Sharma A, Garg A, Elmariah S, Drachman D, Obiagwu C, Vallakati A, Sharma SK, Lavie CJ, Mukherjee D, Waksman R, Stefanini GG, Feres F, Marmur JD, Helft G. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):500-507. doi: 10.1016/j.pcad.2017.12.003. Epub 2017 Dec 24.
  • Yancy CW, Januzzi JL Jr, Allen LA, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Jessup M, Lindenfeld J, Maddox TM, Masoudi FA, Motiwala SR, Patterson JH, Walsh MN, Wasserman A. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 Jan 16;71(2):201-230. doi: 10.1016/j.jacc.2017.11.025. Epub 2017 Dec 22.
  • Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Špinar J, Park JG, White JA, Bohula EA, Braunwald E; IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 2018 Apr 10;137(15):1571-1582. doi: 10.1161/CIRCULATIONAHA.117.030950. Epub 2017 Dec 20.
  • Wasfy JH, Yeh RW. Understanding How to Improve Quality and Value for Patients With Acute Myocardial Infarction. JAMA Cardiol. 2018 Feb 1;3(2):102-103. doi: 10.1001/jamacardio.2017.4779.
  • Greer MM, Kleinman ME, Gordon LB, Massaro J, D’Agostino RB Sr, Baltrusaitis K, Kieran MW, Gordon CM. Pubertal Progression in Female Adolescents with Progeria. J Pediatr Adolesc Gynecol. 2018 Jun;31(3):238-241. doi: 10.1016/j.jpag.2017.12.005. Epub 2017 Dec 16.
  • Ziff OJ, Carter PR, McGowan J, Uppal H, Chandran S, Russell S, Bainey KR, Potluri R. The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry. Int J Cardiol. 2018 Feb 1;252:117-121. doi: 10.1016/j.ijcard.2017.06.033.
  • Reynolds MR, Arias EJ, Derdeyn CP, Kim AH. Transorbital intracranial penetrating trauma with carotid artery injury: a multidisciplinary approach to management. J Neurosurg Sci. 2018 Feb;62(1):89-91. doi: 10.23736/S0390-5616.16.03643-2.
  • Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail. 2018 Apr;6(4):273-285. doi: 10.1016/j.jchf.2017.09.023. Epub 2017 Dec 6.
  • Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE. Predictors and outcomes of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2018 Apr;20(4):651-659. doi: 10.1002/ejhf.1091. Epub 2017 Dec 11.
  • Yong CM, Liu Y, Apruzzese P, Doros G, Cannon CP, Maddox TM, Gehi A, Hsu JC, Lubitz SA, Virani S, Turakhia MP; ACC PINNACLE Investigators. Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry. Am Heart J. 2018 Jan;195:50-59. doi: 10.1016/j.ahj.2017.08.010. Epub 2017 Aug 31.
  • Hess PL, Kennedy K, Cowherd M, Virani SS, Masoudi FA, Navar AM, Yeh RW, Ho PM, Maddox TM. Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project. Am Heart J. 2018 Jan;195:151-152. doi: 10.1016/j.ahj.2017.09.004. Epub 2017 Sep 9.
  • Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Am Heart J. 2018 Jan;195:115-129. doi: 10.1016/j.ahj.2017.09.006. Epub 2017 Sep 12.
  • Secemsky EA, Schermerhorn M, Carroll BJ, Kennedy KF, Shen C, Valsdottir LR, Landon B, Yeh RW. Readmissions After Revascularization Procedures for Peripheral Arterial Disease: A Nationwide Cohort Study. Ann Intern Med. 2018 Jan 16;168(2):93-99. doi: 10.7326/M17-1058. Epub 2017 Dec 5.
  • Singh V, Mendirichaga R, Savani GT, Rodriguez A, Blumer V, Elmariah S, Inglessis-Azuaje I, Palacios I. Comparison of Utilization Trends, Indications, and Complications of Endomyocardial Biopsy in Native Versus Donor Hearts (from the Nationwide Inpatient Sample 2002 to 2014). Am J Cardiol. 2018 Feb 1;121(3):356-363. doi: 10.1016/j.amjcard.2017.10.021. Epub 2017 Oct 31.
  • Yee MK, Nafee T, Daaboul Y, Korjian S, AlKhalfan F, Kerneis M, Wiest C, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM. Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial. J Thromb Thrombolysis. 2018 Jan;45(1):1-8. doi: 10.1007/s11239-017-1583-0.
  • Leshchinskiy S, D’Agostino R. The double channel pylorus. Abdom Radiol (NY). 2018 Aug;43(8):2200-2201. doi: 10.1007/s00261-017-1413-z.
  • O’Hair DP, Bajwa TK, Popma JJ, Watson DR, Yakubov SJ, Adams DH, Sharma S, Robinson N, Petrossian G, Caskey M, Byrne T, Kleiman NS, Zhang A, Reardon MJ. Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device. Ann Thorac Surg. 2018 Feb;105(2):484-490. doi: 10.1016/j.athoracsur.2017.07.051. Epub 2017 Nov 22.
  • McCarthy CP, Januzzi JL Jr. Soluble ST2 in Heart Failure. Heart Fail Clin. 2018 Jan;14(1):41-48. doi: 10.1016/j.hfc.2017.08.005.
  • Flores-Blanco PJ, Cambronero-Sánchez F, Raposeiras-Roubin S, Abu-Assi E, Leithold G, Cobas-Paz R, Rodríguez Serrano AI, Calvo-Iglesias F, Valdés M, Januzzi JL, Iñiguez-Romo A, Manzano-Fernández S. Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y(12) Inhibitors in Patients With Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):538-544. doi: 10.1016/j.rec.2017.10.009. Epub 2017 Nov 14.
  • Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ; REDUCE LAP-HF I Investigators and Study Coordinators. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.
  • Singh A, Collins BL, Gupta A, Fatima A, Qamar A, Biery D, Baez J, Cawley M, Klein J, Hainer J, Plutzky J, Cannon CP, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol. 2018 Jan 23;71(3):292-302. doi: 10.1016/j.jacc.2017.11.007. Epub 2017 Nov 12.
  • Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Toma C, Uretsky B, Garcia S, Moses JW, Parikh M, Kirtane A, Ali ZA, Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry. J Invasive Cardiol. 2018 Mar;30(3):89-96. Epub 2017 Nov 15.
  • Tanabe K, Popma JJ, Kozuma K, Saito S, Muramatsu T, Nakamura S, Namiki A, Morino Y, Hagiwara N, Uematsu M, Kawasaki T, Fujii K, Serruys PW, Onuma Y, Ying S, Kusano H, Stone GW, Kimura T. Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial. EuroIntervention. 2018 Oct 12;14(9):e1020-e1028. doi: 10.4244/EIJ-D-17-00716.
  • Mays AC, Bartels HG, Wistermayer PR, Rohlfing ML, Gentile CM, D’Agostino R Jr, Waltonen JD. Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population. Head Neck. 2018 Jan;40(1):111-119. doi: 10.1002/hed.24992. Epub 2017 Nov 13.
  • Casillas-Berumen S, Rojas-Miguez FA, Farber A, Komshian S, Kalish JA, Rybin D, Doros G, Siracuse JJ. Patient and Aneurysm Characteristics Predicting Prolonged Length of Stay After Elective Open AAA Repair in the Endovascular Era. Vasc Endovascular Surg. 2018 Jan;52(1):5-10. doi: 10.1177/1538574417739747. Epub 2017 Nov 9.
  • Shavadia JS, Southern DA, James MT, Welsh RC, Bainey KR. Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry. Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):274-282. doi: 10.1093/ehjqcco/qcx042.
  • Weintraub WS, Yeh RW. Challenges of Assessing Therapeutic or Diagnostic Outcomes with Observational Data. Am J Med. 2018 Feb;131(2):206-210. doi: 10.1016/j.amjmed.2017.10.027. Epub 2017 Dec 11.
  • Krafcik BM, Farber A, Eberhardt RT, Kalish JA, Rybin D, Doros G, Pike SL, Siracuse JJ. Preoperative Antiplatelet and Statin Use Does Not Affect Outcomes after Carotid Endarterectomy. Ann Vasc Surg. 2018 Jan;46:43-52. doi: 10.1016/j.avsg.2017.10.002. Epub 2017 Nov 1.
  • Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH, Conte JV, Zorn GL 3rd, Hughes GC, Guo J, Popma JJ, Reardon MJ. Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 2018 Feb;105(2):477-483. doi: 10.1016/j.athoracsur.2017.07.017. Epub 2017 Nov 1.
  • Hirai T, Grantham JA, Sapontis J, Cohen DJ, Marso SP, Lombardi W, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Nugent K, Gosch KL, Spertus JA, Salisbury AC; OPEN CTO Study Group. Impact of subintimal plaque modification procedures on health status after unsuccessful chronic total occlusion angioplasty. Catheter Cardiovasc Interv. 2018 May 1;91(6):1035-1042. doi: 10.1002/ccd.27380. Epub 2017 Oct 25.
  • Hwang YC, Morrow DA, Cannon CP, Liu Y, Bergenstal R, Heller S, Mehta C, Cushman W, Bakris GL, Zannad F, White WB. High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. Diabetes Obes Metab. 2018 Mar;20(3):654-659. doi: 10.1111/dom.13136. Epub 2017 Nov 21.
  • Krafcik BM, Cheng TW, Farber A, Kalish JA, Rybin D, Doros G, Siracuse JJ. Perioperative outcomes after reoperative carotid endarterectomy are worse than expected. J Vasc Surg. 2018 Mar;67(3):793-798. doi: 10.1016/j.jvs.2017.08.053. Epub 2017 Oct 16.
  • Patel SM, Menon RV, Burke MN, Jaffer FA, Yeh RW, Vo M, Karmpaliotis D, Azzalini L, Carlino M, Mashayekhi K, Galassi AR, Rinfret S, Ellis SG, Patel M, Rangan BV, Karatasakis A, Danek BA, Karacsonyi J, Resendes E, Banerjee S, Brilakis ES. Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions. J Invasive Cardiol. 2018 Feb;30(2):43-50. Epub 2017 Oct 15.
  • Koshy LM, Aberle LH, Krucoff MW, Hess CN, Mazzaferri E Jr, Jolly SS, Jacobs A, Gibson CM, Mehran R, Gilchrist IC, Rao SV. Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. J Invasive Cardiol. 2018 Jan;30(1):18-22. Epub 2017 Oct 15.
  • Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018 Mar;15(3):355-362. doi: 10.1016/j.hrthm.2017.10.009. Epub 2017 Oct 10.
  • Eisen A, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Cangrelor compared with clopidogrel in patients with prior myocardial infarction – Insights from the CHAMPION trials. Int J Cardiol. 2018 Jan 1;250:49-55. doi: 10.1016/j.ijcard.2017.10.006. Epub 2017 Oct 5.
  • Gibson CM, Basto AN, Howard ML. Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence. Ann Pharmacother. 2018 Mar;52(3):277-284. doi: 10.1177/1060028017737095. Epub 2017 Oct 12.
  • Ference BA, Cannon CP, Landmesser U, Lüscher TF, Catapano AL, Ray KK. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J. 2018 Jul 14;39(27):2540-2545. doi: 10.1093/eurheartj/ehx450.
  • Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018 Jan 1;20(1):157-208. doi: 10.1093/europace/eux275.
  • Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis AB, Davies DW, Day JD, d’Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T; Document Reviewers:. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018 Jan 1;20(1):e1-e160. doi: 10.1093/europace/eux274.
  • Goldstein JA, Dixon SR, Douglas PS, Ohman EM, Moses J, Popma JJ, O’Neill WW. Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study. Catheter Cardiovasc Interv. 2018 Oct 1;92(4):813-817. doi: 10.1002/ccd.27242. Epub 2017 Oct 8.
  • Vaduganathan M, Harrington RA, Stone GW, Steg G, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. EuroIntervention. 2018 Feb 2;13(15):e1841-e1849. doi: 10.4244/EIJ-D-17-00723.
  • Berry SD, Zullo AR, Lee Y, Mor V, McConeghy KW, Banerjee G, D’Agostino RB Sr, Daiello L, Dosa D, Kiel DP. Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model. J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):763-769. doi: 10.1093/gerona/glx147.
  • Yahagi K, Torii S, Ladich E, Kutys R, Romero ME, Mori H, Kolodgie FD, Popma JJ, Virmani R, Finn AV. Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):947-955. doi: 10.1002/ccd.27314. Epub 2017 Sep 12.
  • Butala NM, Secemsky EA, Wasfy JH, Kennedy KF, Yeh RW. Seasonality and Readmission after Heart Failure, Myocardial Infarction, and Pneumonia. Health Serv Res. 2018 Aug;53(4):2185-2202. doi: 10.1111/1475-6773.12747. Epub 2017 Aug 31.
  • Gayat E, Arrigo M, Littnerova S, Sato N, Parenica J, Ishihara S, Spinar J, Müller C, Harjola VP, Lassus J, Miró Ò, Maggioni AP, AlHabib KF, Choi DJ, Park JJ, Zhang Y, Zhang J, Januzzi JL Jr, Kajimoto K, Cohen-Solal A, Mebazaa A; GREAT Network. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 Feb;20(2):345-354. doi: 10.1002/ejhf.932. Epub 2017 Aug 28.
  • Giustino G, Redfors B, Brener SJ, Kirtane AJ, Généreux P, Maehara A, Dudek D, Neunteufl T, Metzger DC, Crowley A, Mehran R, Gibson CM, Stone GW. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):339-347. doi: 10.1177/2048872617719649. Epub 2017 Aug 22.
  • Deng W, Cao J, Chen L, McMullin D, Januzzi JL Jr, Buonanno FS, Lo EH, Ning M. Plasma Glycoproteomic Study of Therapeutic Hypothermia Reveals Novel Markers Predicting Neurologic Outcome Post-cardiac Arrest. Transl Stroke Res. 2018 Feb;9(1):64-73. doi: 10.1007/s12975-017-0558-y. Epub 2017 Aug 15.
  • Eslami MH, Rybin DV, Doros G, Siracuse JJ, Farber A. External validation of Vascular Study Group of New England risk predictive model of mortality after elective abdominal aorta aneurysm repair in the Vascular Quality Initiative and comparison against established models. J Vasc Surg. 2018 Jan;67(1):143-150. doi: 10.1016/j.jvs.2017.05.087. Epub 2017 Aug 12.
  • Gibson CM, Smith CB, Davis S, Scalese MJ. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients. Ann Pharmacother. 2018 Jan;52(1):54-59. doi: 10.1177/1060028017726795. Epub 2017 Aug 11.
  • Lam DH, Glassmoyer LM, Strom JB, Davis RB, McCabe JM, Cutlip DE, Donnino MW, Cocchi MN, Pinto DS. Factors associated with performing urgent coronary angiography in out-of-hospital cardiac arrest patients. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):832-839. doi: 10.1002/ccd.27199. Epub 2017 Aug 2.
  • D’Agostino R. Cloverleaf duodenum. Abdom Radiol (NY). 2018 May;43(5):1270. doi: 10.1007/s00261-017-1275-4.
  • McEvoy D, Gandhi TK, Turchin A, Wright A. Enhancing problem list documentation in electronic health records using two methods: the example of prior splenectomy. BMJ Qual Saf. 2018 Jan;27(1):40-47. doi: 10.1136/bmjqs-2017-006707. Epub 2017 Jul 28.
  • Haider KS, Haider A, Doros G, Traish A. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. J Urol. 2018 Jan;199(1):257-265. doi: 10.1016/j.juro.2017.07.039. Epub 2017 Jul 18.
  • Garg R, Schuman B, Bader A, Hurwitz S, Turchin A, Underwood P, Metzger C, Rein R, Lortie M. Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes After Elective Surgery. Ann Surg. 2018 May;267(5):858-862. doi: 10.1097/SLA.0000000000002323.
  • Ruiz CE, Hahn RT, Berrebi A, Borer JS, Cutlip DE, Fontana G, Gerosa G, Ibrahim R, Jelnin V, Jilaihawi H, Jolicoeur EM, Kliger C, Kronzon I, Leipsic J, Maisano F, Millan X, Nataf P, O’Gara PT, Pibarot P, Ramee SR, Rihal CS, Rodes-Cabau J, Sorajja P, Suri R, Swain JA, Turi ZG, Tuzcu EM, Weissman NJ, Zamorano JL, Serruys PW, Leon MB; Paravalvular Leak Academic Research Consortium. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis. Eur Heart J. 2018 Apr 14;39(15):1224-1245. doi: 10.1093/eurheartj/ehx211.
  • Bayes-Genis A, Voors AA, Zannad F, Januzzi JL, Mark Richards A, Díez J. Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. Eur Heart J. 2018 Aug 7;39(30):2793-2799. doi: 10.1093/eurheartj/ehx027.
  • Lansky AJ, Messé SR, Brickman AM, Dwyer M, Bart van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Scala Moy C, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Eur Heart J. 2018 May 14;39(19):1687-1697. doi: 10.1093/eurheartj/ehx037.
  • Sotomi Y, Onuma Y, Dijkstra J, Miyazaki Y, Kozuma K, Tanabe K, Popma JJ, de Winter RJ, Serruys PW, Kimura T. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial. Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):59-66. doi: 10.1093/ehjci/jew329.
  • Leonardi S, Lopes RD, Steg PG, Abnousi F, Menozzi A, Prats J, Mangum S, Wilson M, Todd M, Stone GW, Gibson CM, Hamm CW, Price MJ, White HD, Harrington RA, Bhatt DL, Mahaffey KW. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):158-165. doi: 10.1177/2048872616661692. Epub 2016 Aug 2.